Jamie Rand, M.D.
"It is wonderful to work in a place where we are all working together toward a common goal of curing cancer and improving the lives of our patients."
Jamie Green Rand, M.D., is a talented breast cancer surgeon determined "to be able to be there for my patients in all aspects of confronting and fighting this disease."
Her fascination with the inner workings of the human body began when she was a small child, watching and learning from her father, an ophthalmologist. Later, as a competitive gymnast, she developed a deeper understanding of body mechanics and the body's ability to heal itself.
Dr. Rand brought that fascination to Yale where she earned a bachelor's degree in molecular biophysics and biochemistry. She earned her medical degree from Weill Cornell Medical College in New York City, completed her internship and residency at New York Presbyterian Hospital-Weill Cornell Medical Center in general surgery, followed by a fellowship in surgical oncology at Cedars-Sinai Medical Center in Los Angeles.
Dr. Rand is excited about the advances in immunotherapy and technology, and focuses her research in these promising areas. She's delighted to join the City of Hope family. "I feel honored to be able to work with such an amazing team of clinicians and scientists at City of Hope to support patients through their treatments and to help improve their quality of life."
Duarte Cancer Center
Duarte, CA 91010
2010, M.D., Weill Cornell Medical College, New York, New York
2004, B.A., Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut
2017-2019, Complex General Surgical Oncology, Cedars-Sinai Medical Center, Los Angeles, California
2011-2017, General Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York
2010-2011, General Surgery, New York Presbyterian Hospital-Weill Cornell Medical Center, New York, New York
2019-present, Assistant Professor, Division of Breast Surgery, Department of Surgery, City of Hope, Duarte, California
American Society of Breast Surgeons
American Association of Cancer Research
Society of Surgical Oncology
American College of Surgeons
American College of Surgeons Resident and Associate Society
American College of Surgeons Professional Association Political Action Committee
Association of Women Surgeons
Los Angeles County Medical Association
Medical Society of the State of New York
- Rand J, Faries M. Omitting Completion Dissection in Melanoma? Help is Available for Surgeons Coping Without Routine Dissection, But More Work is Needed. Annals of Surgical Oncology. 2018 Nov; 25 (12): 3416-3418.
- Ariyan C, Brady M, Siegelbaum R, Hu J, Bello D, Rand J, Fisher C, Lefkowitz R, Panageas K, Pulitzer M, Vignali M, Emerson R, Tipton C, Robins H, Merghoub T, Yuan J, Jungbluth A, Blando J, Sharma P, Rudensky A, Wolchok J, Allison J. Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade. Cancer Immunology Research. 2018 Feb; 6(2):189-200. PMID: 29339377.
- Green J, Ariyan C. “Axillary Dissection.” Skin Cancer and Melanoma: Surgical Treatment and Reconstruction. Ed. Othon Papadopoulos. In publication.
- Green J, Ariyan C. Update on Immunotherapy in Melanoma. Surgical Oncology Clinics of North America. 2015 Apr; 24(2):337-346. PMID: 25769716.
- Green J, Ariyan C. Deploying the body’s army: using patients’ own immune systems to fight cancer. The Scientist. 2014 Apr; 28(4).
- Green JM, Alvero AB, Kohen F, Mor G. 7-(O)-Carboxymethyl daidzein conjugated to N-t-Boc-hexylenediamine: A novel compound capable of inducing cell death in epithelial ovarian cancer stem cells. Cancer Biology and Therapy. 2009 Sep; 8(18): 1747-1754. PMID: 19738422.